AAAAAA

   
Results: 1-10 |
Results: 10
J-104,871, A NOVEL FARNESYLTRANSFERASE INHIBITOR, BLOCKS RAS FARNESYLATION IN-VIVO IN A FARNESYL PYROPHOSPHATE-COMPETITIVE MANNER
Authors: YONEMOTO M SATOH T ARAKAWA H SUZUKITAKAHASHI I MONDEN Y KODERA T TANAKA K AOYAMA T IWASAWA Y KAMEI T NISHIMURA S TOMIMOTO K
Citation: M. Yonemoto et al., J-104,871, A NOVEL FARNESYLTRANSFERASE INHIBITOR, BLOCKS RAS FARNESYLATION IN-VIVO IN A FARNESYL PYROPHOSPHATE-COMPETITIVE MANNER, Molecular pharmacology, 54(1), 1998, pp. 1-7
A NEW CLASS OF HIGHLY POTENT FARNESYL DIPHOSPHATE-COMPETITIVE INHIBITORS OF FARNESYLTRANSFERASE
Authors: AOYAMA T SATOH T YONEMOTO M SHIBATA J NONOSHITA K ARAI S KAWAKAMI K IWASAWA Y SANO H TANAKA K MONDEN Y KODERA T ARAKAWA H SUZUKITAKAHASHI I KAMEI T TOMIMOTO K
Citation: T. Aoyama et al., A NEW CLASS OF HIGHLY POTENT FARNESYL DIPHOSPHATE-COMPETITIVE INHIBITORS OF FARNESYLTRANSFERASE, Journal of medicinal chemistry, 41(2), 1998, pp. 143-147
EFFECTS OF EXOGENOUS P16(INK4A) ON GROWTH OF CELLS WITH VARIOUS STATUS OF CELL-CYCLE REGULATORS
Authors: SUZUKITAKAHASHI I HIGASHI H YOSHIDA E NISHIMURA S KITAGAWA M
Citation: I. Suzukitakahashi et al., EFFECTS OF EXOGENOUS P16(INK4A) ON GROWTH OF CELLS WITH VARIOUS STATUS OF CELL-CYCLE REGULATORS, Biochemical and biophysical research communications, 234(2), 1997, pp. 386-392
EXPRESSION OF P16(INK4A) SUPPRESSES THE UNBOUNDED AND ANCHORAGE-INDEPENDENT GROWTH OF A GLIOBLASTOMA CELL-LINE THAT LACKS P16(INK4A)
Authors: HIGASHI H SUZUKITAKAHASHI I YOSHIDA E NISHIMURA S KITAGAWA M
Citation: H. Higashi et al., EXPRESSION OF P16(INK4A) SUPPRESSES THE UNBOUNDED AND ANCHORAGE-INDEPENDENT GROWTH OF A GLIOBLASTOMA CELL-LINE THAT LACKS P16(INK4A), Biochemical and biophysical research communications, 231(3), 1997, pp. 743-750
THE CONSENSUS MOTIF FOR PHOSPHORYLATION BY CYCLIN D1-CDK4 IS DIFFERENT FROM THAT FOR PHOSPHORYLATION BY CYCLIN A E-CDK2/
Authors: KITAGAWA M HIGASHI H JUNG HK SUZUKITAKAHASHI I IKEDA M TAMAI K KATO J SEGAWA K YOSHIDA E NISHIMURA S TAYA Y
Citation: M. Kitagawa et al., THE CONSENSUS MOTIF FOR PHOSPHORYLATION BY CYCLIN D1-CDK4 IS DIFFERENT FROM THAT FOR PHOSPHORYLATION BY CYCLIN A E-CDK2/, EMBO journal, 15(24), 1996, pp. 7060-7069
CYCLIN-DEPENDENT KINASE-2 (CDK2) FORMS AN INACTIVE COMPLEX WITH CYCLIN D1 SINCE CDK2 ASSOCIATED WITH CYCLIN D1 IS NOT PHOSPHORYLATED BY CDK7-CYCLIN-H
Authors: HIGASHI H SUZUKITAKAHASHI I SAITOH S SEGAWA K TAYA Y OKUYAMA A NISHIMURA S KITAGAWA M
Citation: H. Higashi et al., CYCLIN-DEPENDENT KINASE-2 (CDK2) FORMS AN INACTIVE COMPLEX WITH CYCLIN D1 SINCE CDK2 ASSOCIATED WITH CYCLIN D1 IS NOT PHOSPHORYLATED BY CDK7-CYCLIN-H, European journal of biochemistry, 237(2), 1996, pp. 460-467
THE INTERACTIONS OF E2F WITH PRB AND WITH P107 ARE REGULATED VIA THE PHOSPHORYLATION OF QRB AND P107 BY A CYCLIN-DEPENDENT KINASE
Authors: SUZUKITAKAHASHI I KITAGAWA M SAIJO M HIGASHI H OGINO H MATSUMOTO H TAYA Y NISHIMURA S OKUYAMA A
Citation: I. Suzukitakahashi et al., THE INTERACTIONS OF E2F WITH PRB AND WITH P107 ARE REGULATED VIA THE PHOSPHORYLATION OF QRB AND P107 BY A CYCLIN-DEPENDENT KINASE, Oncogene, 10(9), 1995, pp. 1691-1698
PHOSPHORYLATION OF E2F-1 BY CYCLIN A-CDK2
Authors: KITAGAWA M HIGASHI H SUZUKITAKAHASHI I SEGAWA K HANKS SK TAYA Y NISHIMURA S OKUYAMA A
Citation: M. Kitagawa et al., PHOSPHORYLATION OF E2F-1 BY CYCLIN A-CDK2, Oncogene, 10(2), 1995, pp. 229-236
DIFFERENCES IN SUBSTRATE-SPECIFICITY BETWEEN CDK2-CYCLIN-A AND CDK2-CYCLIN-E IN-VITRO
Authors: HIGASHI H SUZUKITAKAHASHI I TAYA Y SEGAWA K NISHIMURA S KITAGAWA M
Citation: H. Higashi et al., DIFFERENCES IN SUBSTRATE-SPECIFICITY BETWEEN CDK2-CYCLIN-A AND CDK2-CYCLIN-E IN-VITRO, Biochemical and biophysical research communications, 216(2), 1995, pp. 520-525
BUTYROLACTONE-I, A SELECTIVE INHIBITOR OF CDK2 AND CDC2 KINASE
Authors: KITAGAWA M OKABE T OGINO H MATSUMOTO H SUZUKITAKAHASHI I KOKUBO T HIGASHI H SAITOH S TAYA Y YASUDA H OHBA Y NISHIMURA S TANAKA N OKUYAMA A
Citation: M. Kitagawa et al., BUTYROLACTONE-I, A SELECTIVE INHIBITOR OF CDK2 AND CDC2 KINASE, Oncogene, 8(9), 1993, pp. 2425-2432
Risultati: 1-10 |